Pelargonium sidoides - from ethnopharmacology to evidence-based medicine: a systematic review.
Study Design
- Loại nghiên cứu
- Systematic Review
- Đối tượng nghiên cứu
- patients with acute bronchitis, rhinosinusitis, and tonsillopharyngitis
- Can thiệp
- Pelargonium sidoides - from ethnopharmacology to evidence-based medicine: a systematic review. None
- Đối chứng
- None
- Kết quả chính
- clinical efficacy of Pelargonium sidoides for respiratory tract infections
- Xu hướng hiệu quả
- Positive
- Nguy cơ sai lệch
- Unclear
Abstract
BACKGROUND: Pelargonium sidoides DC. (Geraniaceae) has a long history of traditional use among indigenous peoples of Southern Africa for treating respiratory and gastrointestinal disorders. Its transformation into the modern pharmaceutical product Umckaloabo (EPs® 7630) exemplifies the transition from traditional medicine to evidence-based therapeutics. PURPOSE: To provide a systematic analysis of P. sidoides, spanning from its botanical characteristics and ethnobotanical roots to its development as a regulated phytomedicine. The review focuses on the plant's unique phytochemical profile and provides a detailed synthesis of its molecular and systems-biological mechanisms of action, cultivation sustainability, and clinical efficacy in managing respiratory tract infections. STUDY DESIGN AND METHODS: A systematic search was conducted across PubMed, Scopus, and Cochrane Library up to December 2025 following PRISMA guidelines. Sources included scientific articles, pharmacopoeias, patents, and ethnobotanical records in English and Ukrainian. RESULTS: The systematic synthesis of identified records characterizes the chemical diversity of P. sidoides, focusing on specialized metabolites such as highly substituted benzopyranones, prodelphinidins, and unique coumarin sulfates. The review discusses modern cultivation practices, sustainability issues, and comparative extraction techniques, while analytical methods such as HPLC, LC-MS, and TLC for standardization are summarized. The pharmacological profile is defined by multi-target activity, encompassing immunomodulatory, antibacterial, and antiviral effects, including studies on SARS-CoV-2 and other respiratory pathogens. Analysis of available clinical data validates the therapeutic use of P. sidoides root preparations for managing acute bronchitis, rhinosinusitis, and tonsillopharyngitis. CONCLUSION: This study demonstrates that the integration of P. sidoides into modern healthcare is supported by the synergy between traditional knowledge and molecular and clinical validation. By mapping the developmental trajectory - from wild harvesting to systems-biological evidence - this review identifies P. sidoides as a model for the pharmaceutical translation of ethnobotanical resources into standardized, evidence-based phytomedicines.
Tóm lược
This study demonstrates that the integration of P. sidoides into modern healthcare is supported by the synergy between traditional knowledge and molecular and clinical validation, and identifies P. sidoides as a model for the pharmaceutical translation of ethnobotanical resources into standardized, evidence-based phytomedicines.
Used In Evidence Reviews
Similar Papers
Journal of ethnopharmacology · 2008
A historical, scientific and commercial perspective on the medicinal use of Pelargonium sidoides (Geraniaceae).
Phytomedicine : international journal of phytotherapy and phytopharmacology · 2011
Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses.
The Cochrane database of systematic reviews · 2013
Pelargonium sidoides extract for treating acute respiratory tract infections.
Antiviral research · 2012
EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo.
Phytomedicine : international journal of phytotherapy and phytopharmacology · 2003
Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial.
Phytomedicine : international journal of phytotherapy and phytopharmacology · 2008